Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
112,679
-
Share change
-
+34,700
-
Total reported value
-
$148,604
-
Price per share
-
$1.31
-
Number of holders
-
12
-
Value change
-
+$45,604
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) as of Q3 2024
As of 30 Sep 2024 ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 112,679 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, HB Wealth Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, CITADEL ADVISORS LLC, Twin Lakes Capital Management, LLC, Providence Capital Advisors, LLC, OSAIC HOLDINGS, INC., Blue Trust, Inc., and Sugarloaf Wealth Management, LLC.
This table shows 12 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.